James A Geraghty

James A Geraghty has an estimated net worth of $4.22 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, Fulcrum Therapeutics, Inc., PIERIS PHARMACEUTICALS, INC., Voyager Therapeutics, Inc., IDERA PHARMACEUTICALS, INC., Orchard Therapeutics plc, JUNIPER PHARMACEUTICALS INC, and GTC BIOTHERAPEUTICS INC.

2016 was James A Geraghty's most active year for acquiring shares with 10 total transactions. James A Geraghty's most active month to acquire stocks was the month of May. 2011 was James A Geraghty's most active year for disposing of shares, totalling 15 transactions. James A Geraghty's most active month to dispose stocks was the month of March. 2009 saw James A Geraghty paying a total of $1,210,425.70 for 70,791 shares, this is the most they've acquired in one year. In 2009 James A Geraghty cashed out on 73,750 shares for a total of $1,920,081.25, their largest year based on trade value.